The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

On the one hand, its impressive business performance can make investors ponder potential life-changing investment returns. Conversely, feeling confident in Hims & Hers Health can sometimes be ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

My weight concerns mainly injure my considerable vanity, and I’m not about to outsource my self-esteem issue to Big Pharma if ...

One such breakthrough is GLP-1 receptor agonist (GLP-1 RA ... Increased access to cheap, high-calorie processed foods. - Low levels of physical activity due to modern work environments and ...

Discover three oversold biotech/biopharma stocks to watch amidst market volatility and the JP Morgan Healthcare event in San ...

Merck has partnered with Hansoh, a Chinese biopharmaceutical company, for a global licensing deal to develop an oral GLP-1 receptor agonist for ... our report about the cheapest AI stock.

Their VK2735 drug is a GLP-1 dual agonist being developed for patients ... check out our report about the cheapest AI stock.

Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals.

Some speculate that GLP-1 agonists will cause people to drop their sugar cravings, and new competition has sprung up from upstart brands. Like PepsiCo, Hershey's stock is seldom cheap under normal ...